“…Interestingly, numerous studies have shown that RPRD1B is highly expressed in a majority of solid tumors, where it promotes cell proliferation, tumor growth and progression. Furthermore, its levels correlate with poor prognosis and overall survival ( Li et al, 2018 ; Liu et al, 2019 ; Lu et al, 2012 ; Ma et al, 2020 ; Ma et al, 2017 ; She et al, 2014 ; Wang et al, 2014b ; Wen et al, 2020 ; Yin et al, 2019 ; Zhang et al, 2018 ; Zheng et al, 2016 ). RPRD proteins can modulate CTD Serine 5 (Ser5) and Ser7 phosphorylation levels, likely through the recruitment of the phosphatase RPAP2 ( Ni et al, 2011 ; Ni et al, 2014 ).…”